in the news
No items found.

Showing
1–25
of 100
SortPharmaVoice: How a Biotech Exec is Leveraging Big Pharma Lessons to Advance tRNATechnology Networks: Tuning the Therapeutic Properties of tRNAs To Treat Rare DiseasesInside Precision Medicine: In Conversation with Michelle WernerLabiotech.eu: Wrapping up 2023: A Recap of Top Biotech Moments of This YearRaising Biotech Podcast (Episode 6): Alltrna and tRNA Therapeutics for Rare Genetic DiseasesPM360 Magazine: Alltrna Named a 2023 Innovative StartupAlldus AI in Action Podcast (Episode 490): Theonie Anastassiadis & Stephen EichhornBeyond Biotech Podcast (Episode 66): Treating Rare Diseases with tRNABiotech 2050 Podcast: Pioneering tRNA Therapeutics with Michelle WernerPharmaVoice 100 Stand-out Execs: Michelle WernerIn Vivo: Exploring Alltrna’s Rare Disease PlatformThe Scientist: The Origins and Recent Promise of Nonsense Suppressor tRNAsMedCity News: Alltrna Unveils $109M to Make tRNA a Universal Therapy for Genetic DiseasesBoston Business Journal: Flagship-backed RNA startup company raises $109MBioPharma Dive: Alltrna raises $109M for ‘transfer RNA’ drug vision
Apr 29, 2024
Article
[ExtERNAL]
Apr 29, 2024
Press Release
[ExtERNAL]
Feb 7, 2024
Press Release
[ExtERNAL]
Dec 20, 2023
Article
[ExtERNAL]
Dec 19, 2023
Podcast
[ExtERNAL]
Dec 14, 2023
Award
[ExtERNAL]
Dec 4, 2023
Podcast
[ExtERNAL]
Oct 6, 2023
Podcast
[ExtERNAL]
Sep 25, 2023
Podcast
[ExtERNAL]
Sep 19, 2023
Award
[ExtERNAL]
Sep 14, 2023
Article
[ExtERNAL]
Sep 6, 2023
Article
[ExtERNAL]
Aug 9, 2023
Article
[ExtERNAL]
Aug 9, 2023
Article
[ExtERNAL]
Aug 9, 2023
Article
[ExtERNAL]
Stay connected
Get the latest updates as we advance tRNA therapeutics with the potential to treat thousands of diseases.
